Search PubMed⌕ Search

Biomedical subjects

B Millar

Publications and source records attributed to B Millar.

At least 145 records · Page 8Linked to original sources
PubMed1991

Study of belching ability in antireflux surgery patients and normal volunteers.

The ability to belch was evaluated by a novel test, after gaseous stomach distension to standard volume, in 16 patients after antireflux surgery and nine healthy volunteers. A structured assessment of dyspeptic symptoms was also carried out in both groups. Repeat studies in volunteers showed acceptable reproducibility for the new test of belching capacity (within-subject coefficient of variance 4.5 per cent). After antireflux surgery, patients had lower volume individual belches (median(range) 27.5(0-104) ml in patients versus 76(15-165) ml in volunteers; P less than 0.02) and belched less gas within 1 h of the stimulus than volunteers (median(range) 205(0-1363) ml in patients versus 456(45-818) ml in volunteers; P less than 0.05). Belching frequency was similar in both groups. The incidence and severity of symptoms were unrelated to belched gas volumes.

Adult↗
PubMed1991

Spot-welded wire hooks as seating guides for resin-bonded castings.

A technique is described to assist in accurate positioning of cast metal, resin-bonded prostheses. The method is particularly useful for the recementation of castings but can also be used with new restorations. A piece of rectangular chrome alloy arch wire is annealed and spot-welded to the retainer. The wire is then adapted to lie over the incisal edge of the abutment tooth and forms a locating device during trying in and cementing of the restoration. The wire hook assists in the handling of the casting at chairside and is easily snapped off after cementation, leaving little finishing to be completed. The technique permits access to all of the marginal surfaces at cementation and offers certain advantages over existing alternative techniques.

Cementation↗
PubMed1989

Intensive treatment of multiple myeloma and criteria for complete remission.

50 previously untreated patients with multiple myeloma received two-phase treatment: repeated cycles of 4 day infusion with vincristine, doxorubicin, and methylprednisolone (VAMP) followed by high-dose melphalan (HDM), with autologous bone marrow transplantation where possible. The overall response rate was 74% (37/50), with 25 patients (50%) achieving complete haematological and biochemical remission. These remissions were associated with a good quality of life as measured by performance status, pain grade, and the reversal of humoral immunosuppression. 6 patients died during the VAMP phase and there was 1 death related to HDM. The achievement of complete remission, as defined here, in such a high proportion of patients is exceptional and may represent a useful advance in the management of myeloma.

Adult↗